30/03/2014 - 13:00
A trial of aleglitazar to improve cardiovascular outcomes in patients with type 2 diabetes who had recent-onset acute coronary syndrome has been terminated early because of a lack of efficacy and an...
Field of Interest: Cardiology
Categories:
News Feed: Internal Medicine News - Cardiology